Replies to post #1237 on Arena Pharmaceuticals, Inc. (ARNA)

[JJM760]

I agree with you. I think that unless you dig deeper than the surface of the story, it appears that Loc is DOA as Dew claimed a while back. Especially in light of contrave getting the panel nod, I think Loc has a decent chance at approval. The stock price shows essentially no value for the drug what so ever. My basis is $1.80 and I am taking a chance that the FDA meeting produces something positive for ARNA. We shall see sooner than later